MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20253826

April 8, 2025

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄计)

化学药品

April 8, 2025

Company Information

Applicant Company

山东省济南市高新区春兰路1177号银丰国际生物城B6栋

Manufacturing Company

山西省大同市经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath